Steven Cohen Ocular Therapeutix, Inc Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,942,362 shares of OCUL stock, worth $16.9 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,942,362
Previous 2,935,924
33.84%
Holding current value
$16.9 Million
Previous $25.1 Million
43.22%
% of portfolio
0.04%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding OCUL
# of Institutions
207Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$125 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$121 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$111 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$100 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.36MShares$72.9 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $670M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...